Economic and relationship support to reduce alcohol use in Malawi

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention aims to evaluate the effectiveness and cost-efficiency of Mlambe, which combines incentivized savings accounts, financial literacy training, and relationship skills education to address heavy drinking among HIV-affected couples in Malawi. By focusing on the couple dynamic rather than individual behavior, the study seeks to strengthen relationships and improve communication, ultimately reducing alcohol consumption. The intervention is designed to tackle the intertwined issues of alcohol use, intimate partner violence, and economic insecurity that affect health outcomes for people living with HIV. The study will employ a full-scale randomized control trial to assess the impact of these combined strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. In a married or cohabitating union
2. Have at least one partner with a positive AUDIT-C screen in prior 3 months
3. Must also currently be on ART for at least 6 months
4. Must have disclosed their HIV status to their partner

Exclusion Criteria:

1\) Severe intimate partner violence reported in previous 3 months and/or fear that safety would be at risk by participation in the study (reported at screening). Couples who participated in Mlambe's pilot study will also be excluded.

Where it's running

• Invest in Knowledge Initiative (IKI)
  Zomba, Malawi Recruiting

Study contacts

• Principal investigator: Amy Conroy, PhD — University of California, San Francisco
• Study coordinator: James Mkandawire
• Email: james3mkandawire@gmail.com
• Phone: +265 8883 70081

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Peer-led Dynamic Choice HIV Prevention for Women

  This trial tests a peer-led HIV prevention approach to see if it helps women at higher risk in Uganda better prevent HIV than standard care.

  Recruiting University of California, San Francisco · Kampala · NCT07787988

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Transcutaneous auricular neurostimulation (tAN) for reducing alcohol withdrawal in people with alcohol use disorder

  This trial will try a five-day ear‑stimulation device (tAN) versus a sham device to reduce alcohol withdrawal symptoms in adults with moderate-to-severe alcohol use disorder.

  Recruiting Spark Biomedical, Inc. · Houston, Texas · NCT07281261

• BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for adults with alcohol use disorder

  This study will test whether BrainsWay Deep TMS can reduce heavy drinking in adults with moderate to severe alcohol use disorder compared with a sham procedure.

  Recruiting at 9 sites Brainsway · Tuscaloosa, Alabama and 10 other locations · NCT07216872

• Improving long-term medication adherence for HIV treatment

  This study is testing whether daily text messages and rewards can help people starting HIV treatment stick to their medication plan over the long term.

  Recruiting Rand · Kampala · NCT06949774

• Reducing alcohol use and improving HIV treatment for men in fishing communities

  This study is testing a new program to help men with HIV in fishing communities cut down on drinking and stick to their HIV treatment to improve their health.

  Recruiting San Diego State University · Kampala · NCT06771843

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.